Cancer clinical trials in the region Pays de la Loire

199 currently recruiting clinical trials
Region Pays de la Loire

Phase 2 Lung cancer
#NCT06552234
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ROS-1 Systemic Treatment-Naive Immunotherapy Chemotherapy Targeted therapy None 1 2 3 or more
6 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2 Breast cancer
#NCT04862663
HER2 Negative HR Positive Locally Advanced Metastatic
Targeted therapy
5 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
AstraZeneca
Phase 2 Lung cancer
#NCT04884282
NSCLC (Non-Small Cell Lung Cancer) Metastatic Other mutation Immunotherapy Chemotherapy 1
ALK EGFR ROS-1 Systemic Treatment-Naive
8 main criterias to confirm
Centre Hospitalier de Cholet (Cholet)
Fondazione Ricerca Traslazionale
Phase 2 Breast cancer
#NCT04561362
HER2 Negative HR Negative Locally Advanced Metastatic Other mutation
Systemic Treatment-Naive
6 main criterias to confirm
Centre Eugene Marquis (Rennes)
BicycleTx Limited
Phase 2 Lung cancer
#NCT04561362
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic Other mutation
ALK EGFR ROS-1 Systemic Treatment-Naive
6 main criterias to confirm
Centre Eugene Marquis (Rennes)
BicycleTx Limited
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer
#NCT05118789
SCLC (Small Cell Lung Cancer) Mesothelium Locally Advanced Metastatic Metastatic Castration-resistant ROS-1 1
Systemic Treatment-Naive
6 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Nuvalent Inc.
Phase 2 Breast cancer
#NCT06247995
HER2 Negative HR Positive Metastatic Targeted therapy Hormone therapy 1 2 3 or more
Chemotherapy
7 main criterias to confirm
Centre Hospitalier Universitaire Laennec (Saint-Herblain)
Novartis
Phase 2 Breast cancer
#NCT06078384
HER2 Negative HR Negative Localized Surgery Systemic Treatment-Naive
Immunotherapy
7 main criterias to confirm
Centre Eugene Marquis (Rennes)
UNICANCER
Phase 2 Breast cancer
#NCT05955170
HER2 Positive Metastatic Chemotherapy Targeted therapy Chemotherapy Targeted therapy 1
6 main criterias to confirm
Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Institut Curie
Phase 2 Lung cancer
#NCT05856695
SCLC (Small Cell Lung Cancer) Metastatic Systemic Treatment-Naive None
5 main criterias to confirm
Centre Hospitalier de Cholet (Cholet), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier du Mans (Le Mans), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Régional Universitaire de Tours (Tours)
Intergroupe Francophone de Cancérologie Thoracique